Hair Loss on GLP-1 Medications: What Causes It and How to Stop It

Not directly — but it can trigger it. In the SURMOUNT-1 trial of tirzepatide, 4.9% of participants reported hair loss, compared with 0.9% on placebo (Jastreboff AM, et al., *NEJM*, 2022). The STEP 1 trial of semaglutide showed similar numbers: 3.0% of the semaglutide group versus 1.0% of placebo (Wilding JPH, et al., *NEJM*, 2021). These are real but modest signals.

The mechanism isn't the medication binding to a hair follicle receptor. It's telogen effluvium — a temporary shedding pattern triggered by any major physiological stressor: childbirth, surgery, illness, rapid weight loss, or significant calorie restriction. Hair follicles cycle through growing (anagen), resting (telogen), and shedding phases. A stressor pushes a large proportion of follicles into the resting phase simultaneously, and they all shed about three months later.

For context, 40-70% of bariatric surgery patients experience hair loss in the year after surgery — roughly ten times the rate seen on GLP-1 medications (Goldberg D, et al., *Obesity Surgery*, 2020). The lower rate on GLP-1s likely reflects a slower, more gradual weight loss curve.

Most people notice shedding between month 3 and month 6 of treatment — right around the time they hit the higher doses and the weight loss accelerates. The shedding typically lasts 2-4 months, then tapers. By month 9-12, regrowth is usually visible at the hairline and crown.

The shedding pattern matters. Diffuse thinning across the scalp is the normal pattern for telogen effluvium. If you're seeing patchy bald spots, sudden loss in distinct circles, or scalp pain — that's a different condition (alopecia areata, traction alopecia, or scalp inflammation) and worth a dermatology referral. It's not from the GLP-1.

Losing 100-150 hairs per day is normal. During a telogen effluvium episode, that can climb to 300-500 hairs per day, which is alarming but rarely results in visible scalp showing through. The hair feels thinner and the ponytail circumference drops, but most people aren't going bald.

Check if it's truly excessive with a simple test: gently run your hand through dry hair four times. More than 5-6 hairs coming out each time, repeated over a few weeks, suggests active shedding. Less than that is usually within normal range.

The pattern matters more than the count. If you see your scalp becoming visible at the crown, recession at the temples, or distinct bald patches, talk to a dermatologist — those patterns suggest something other than telogen effluvium.

Hair is made of keratin, which is essentially structural protein. Inadequate protein intake is the single biggest driver of GLP-1 hair loss. Many GLP-1 users find themselves eating 40-60g of protein per day because appetite drops — that's far below the 1.2-1.6g per kg of body weight that maintains hair, muscle, and skin during active weight loss.

The other key nutrient is iron. Ferritin levels under 50 ng/mL are independently associated with hair shedding in women, even without overt anemia (Trost LB, et al., *J Am Acad Dermatol*, 2006). Ask your provider to check ferritin specifically — not just hemoglobin. Many women on GLP-1s discover sub-clinical iron deficiency that resolves with supplementation and accelerates regrowth.

Beyond protein and iron, the high-impact nutrients are vitamin D (target 40-60 ng/mL), zinc (8-11mg daily), and biotin — though biotin's effect on hair is overstated; the real win is the broader B-complex.

If you're struggling to hit protein targets because appetite is so low, our guide on [protein needs on GLP-1 during menopause](/blog/protein-needs-on-glp-1-during-menopause-sarcopenia-strategy) breaks down practical strategies.

Possibly — but it depends on the rate. Losing more than 1.5% of body weight per week is the threshold above which telogen effluvium risk climbs sharply. A 200-pound woman losing 3+ pounds per week is in that zone.

Dropping back to the previous dose for 4-6 weeks, or holding at a lower maintenance dose, slows the rate of loss and gives follicles a chance to recover. This isn't medical advice for your specific case — dose adjustments belong with your prescriber — but it's a reasonable conversation to have if hair loss is significant.

One thing not to do: stop the medication abruptly because of hair loss. The hair loss is already in motion and won't reverse for 3-6 months regardless. Stopping the medication usually means weight regain, which is its own stressor and can trigger another round of shedding.

Topical minoxidil (Rogaine) at 5% can shorten the recovery time and help follicles re-enter the growth phase. It's safe to use during GLP-1 treatment and is the most evidence-backed topical option. Expect 3-6 months before seeing visible results — and know that you'll get an initial shed when you start, which is normal.

Oral supplements are mostly hype. Nutrafol and similar formulas contain some real ingredients (saw palmetto, ashwagandha, marine collagen) but the evidence is thin, and the cost is high. The same money spent on extra protein and a basic multivitamin usually does more.

Collagen peptides are popular but probably unnecessary if you're hitting your protein target — your body breaks collagen down into the same amino acids it gets from any complete protein source. Biotin has a real deficiency-treatment use but doesn't help in non-deficient people.

For a fuller look at the GLP-1 nutrition framework, see our [protein needs on GLP-1 guide](/blog/protein-needs-on-glp-1-during-menopause-sarcopenia-strategy).

If you're seeing shedding and want a personalized check-in — whether it's the timing of your dose, your current protein intake, or whether to ask your provider about ferritin — Lea can walk you through it. She knows the typical timeline on your specific medication and can help you spot whether what you're seeing fits the normal pattern or warrants a conversation with your provider.